Capnia Provides Corporate Update and Reports First Quarter 2017 Financial Results

REDWOOD CITY, Calif., May 11, 2017 (GLOBE NEWSWIRE) — Capnia, Inc. (CAPN), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today provided a corporate update following its recent annual meeting and announced financial results for the three months ended March 31, 2017.